Your browser doesn't support javascript.
loading
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.
Visvanathan, Kala; Fabian, Carol J; Bantug, Elissa; Brewster, Abenaa M; Davidson, Nancy E; DeCensi, Andrea; Floyd, Justin D; Garber, Judy E; Hofstatter, Erin W; Khan, Seema A; Katapodi, Maria C; Pruthi, Sandhya; Raab, Rachal; Runowicz, Carolyn D; Somerfield, Mark R.
Afiliação
  • Visvanathan K; Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Fabian CJ; University of Kansas Medical Center, Kansas City, KS.
  • Bantug E; Johns Hopkins School of Medicine, Baltimore, MD.
  • Brewster AM; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Davidson NE; University of Washington, Seattle, WA.
  • DeCensi A; National Hospital E.O. Ospedali Galliera S.C. Oncologia Medica, Genoa, Italy; and Queen Mary University of London, United Kingdom.
  • Floyd JD; Cancer Care Specialists of Illinois, Swansea, IL.
  • Garber JE; Dana-Farber Cancer Institute, Boston, MA.
  • Hofstatter EW; Yale Cancer Center, New Haven, CT.
  • Khan SA; Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Katapodi MC; University of Basel Nursing Science, Basel, Switzerland.
  • Pruthi S; Mayo Clinic Cancer Center, Rochester, MN.
  • Raab R; Cancer Care of Western North Carolina, Asheville, NC.
  • Runowicz CD; Florida International University, Miami, FL.
  • Somerfield MR; American Society of Clinical Oncology, Alexandria, VA.
J Clin Oncol ; 37(33): 3152-3165, 2019 11 20.
Article em En | MEDLINE | ID: mdl-31479306

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article